This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
WellCare Health Arm MeridianRx Unveils Mobile Application
by Zacks Equity Research
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Molina (MOH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $140.13, marking a -1.16% move from the previous day.
4 HMO Q4 Outperformers Likely to Retain Beat Streak in Q1
by Srijita Guha
Based on a few key factors, we zero in on four HMO stocks that are set to retain the bull run in first-quarter 2019.
Is Molina Healthcare (MOH) a Good Pick For Value Investors?
by Zacks Equity Research
Molina Healthcare (MOH) stock may be a good choice for value-oriented investors right now from multiple angles.
Molina (MOH) Up 7.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Magellan Health Down Nearly 40%, in a Year: What's Next?
by Zacks Equity Research
Stiff competition and subdued profitability is weighing on shares of Magellan Health (MGLN).
Top Ranked Growth Stocks to Buy for March 11th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 11th:
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
5 Stocks That Rose More Than 100% in the Trump Era
by Swarup Gupta
President Trump appreciates that a U.S.-China trade deal would significantly extend the current market rally.
Zacks.com featured highlights include: Fortinet, Commvault, WNS and Molina
by Zacks Equity Research
Zacks.com featured highlights include: Fortinet, Commvault, WNS and Molina
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Lucrative Liquid Stocks for Remarkable Returns
by Zacks Equity Research
Four top-ranked liquid stocks that investors can bank on for handsome returns.
Top Ranked Growth Stocks to Buy for March 1st
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, March 1st:
Universal Health's (UHS) Q4 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results gain from its healthy top-line growth.
Top Ranked Growth Stocks to Buy for February 27th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 27th:
Top Ranked Growth Stocks to Buy for February 26th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 26th:
Top Ranked Growth Stocks to Buy for February 22nd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 22nd
What Trade Wars Do to Stocks
by John Blank
The U.S. and China Damaged, But Did Not Break Global Trade.
Zacks.com featured highlights include: Crocs, Commvault, Fortinet, WNS and Molina
by Zacks Equity Research
Zacks.com featured highlights include: Crocs, Commvault, Fortinet, WNS and Molina
Check These 5 Top-Ranked Liquid Stocks for Alluring Returns
by Zacks Equity Research
Here are five top-notch liquid stocks that investors can cling on to for remarkable returns.
Here's Why Investing in Molina Healthcare (MOH) Makes Sense
by Zacks Equity Research
Banking on higher net income and a solid 2018 performance, Molina Healthcare (MOH) holds potential as a promising investment option.
Zacks.com featured highlights include: Take-Two, Molina, Wright Medical, CommVault and WNS
by Zacks Equity Research
Zacks.com featured highlights include: Take-Two, Molina, Wright Medical, CommVault and WNS
Molina Healthcare (MOH) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter earnings trump estimates on the back of lower costs and higher premium revenues.
Molina (MOH) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 155.26% and 2.25%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?